✦ LIBER ✦

Outcome of Treatment of Chronic Myeloid Leukemia With Second-Generation Tyrosine Kinase Inhibitors After Imatinib Failure

✍ Scribed by A. Megan Cornelison; Hagop Kantarjian; Jorge Cortes; Elias Jabbour

Book ID: 119218712
Publisher: Elsevier
Year: 2011
Tongue: English
Weight: 414 KB
Volume: 11
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2011.02.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcome After Failure of Second Generati

Outcome After Failure of Second Generation Tyrosine Kinase Inhibitors Treatment As First-line Therapy for Patients With Chronic Myeloid Leukemia

✍ Eghtedar, Alireza; Kantarjian, Hagop; Jabbour, Elias; O'Brien, Susan; Burton, El 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 439 KB

Second-generation tyrosine kinase inhibi

Second-generation tyrosine kinase inhibitors in chronic myelogenous leukemia : Before or after imatinib?

✍ Ayalew Tefferi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Imatinib should continue to be the front‐line therapy for patients who have newly diagnosed chronic myelogenous leukemia accompanied by close monitoring. Patients should switch to a second‐generation tyrosine kinase inhibitor at the earliest sign of resistance or suboptimal response to imatinib.

Sustained complete molecular response of

Sustained complete molecular response of chronic myeloid leukemia after discontinuation of second-generation tyrosine kinase inhibitors

✍ Aoki, Jun; Ohashi, Kazuteru; Kobayashi, Takeshi; Kakihana, Kazuhiko; Hirashima, 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 229 KB

The Achievement of a 3-Month Complete Cy

The Achievement of a 3-Month Complete Cytogenetic Response to Second-Generation Tyrosine Kinase Inhibitors Predicts Survival in Patients With Chronic Phase Chronic Myeloid Leukemia After Imatinib Failure

✍ Jabbour, Elias; Kantarjian, Hagop; Ghanem, Hady; O'Brien, Susan; Quintas-Cardama 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 305 KB

Long-term outcomes in the second-line tr

Long-term outcomes in the second-line treatment of chronic myeloid leukemia : A review of tyrosine kinase inhibitors

✍ Elias Jabbour; Jorge Cortes; Hagop Kantarjian 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 1 views

Hammersmith score application identifies

Hammersmith score application identifies chronic myeloid leukemia patients with poor prognosis before treatment with second-generation tyrosine kinase inhibitors

✍ Massimo Breccia; Fabio Stagno; Antonella Gozzini; Elisabetta Abruzzese; Roberto 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB